Cargando…

A87 PERSPECTIVES ON DIET MODIFICATION TO MANAGE THEIR SYMPTOMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. A SCOPING REVIEW

BACKGROUND: The link between diet, disease activity and symptoms in IBD patients have recently gained attention and recommendations on dietary interventions to manage symptoms are common. Most studies have explored the correlation between dietary patterns and increased risk of IBD or symptom severit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noejovich, C V, Yuan, C, Miranda, P, Szeto, J, Patel, R, Armstrong, D, Verdu, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991376/ http://dx.doi.org/10.1093/jcag/gwac036.087

Ejemplares similares

Inflammatory arthritis associated with inflammatory bowel disease in children
por: Desgranges, M, et al.
Publicado: (2008)

Genetic polymorphisms of inflammatory molecules in Tunisian inflammatory bowel diseases
por: Gorgi, Y, et al.
Publicado: (2010)

P87 - A national multicenter registration of treatment with omalizumab in Danish asthmatic children
por: Spangenberg, Katrine B, et al.
Publicado: (2014)

A214 WOMEN WITH INFLAMMATORY BOWEL DISEASE HAVE INCREASED HEALTH-CARE UTILIZATION DURING PREGNANCY AND POSTPARTUM COMPARED TO THOSE WITHOUT INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED COHORT STUDY
por: Tandon, P, et al.
Publicado: (2023)

Inflammatory Bowel Disease: Are Symptoms and Diet Linked?
por: Morton, Hannah, et al.
Publicado: (2020)

A171 INTESTINAL INTERFERON-LAMBDA RECEPTOR 1 EXPRESSION AND RESPONSES ARE SIGNIFICANTLY DECREASED IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
por: Ogungbola, O, et al.
Publicado: (2023)

P02.87. Ayurvedic management of Ulcerative Colitis: a non-randomized, observational cinical study
por: Kalapi, P, et al.
Publicado: (2012)

P04.87. Are people with known coronary risk factors more likely to use dietary supplements?
por: Zamora, D, et al.
Publicado: (2012)

P87 Paradigms about the COVID-19 pandemic: knowledge, attitudes and practices from medical students
por: Lincango-Naranjo, Eddy, et al.
Publicado: (2021)

A19 INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN IRRITABLE BOWEL SYNDROME PATIENTS WITH PERCEIVED GLUTEN SENSITIVITY
por: Seiler, C, et al.
Publicado: (2023)

Colorectal cancer risk in patients with inflammatory bowel disease and Lynch syndrome
por: Aronson, Melyssa, et al.
Publicado: (2010)

A202 INVESTIGATION OF THE DIRECT EFFECT OF HEMIN-HEMOPEXIN AND HAPTOGLOBIN STIMULATION IN INFLAMMATORY BOWEL DISEASE
por: Ajayi, A S, et al.
Publicado: (2023)

A197 INVESTIGATING THE PROTON-PUMP INHIBITOR USE PRECEDING AND POST AN INFLAMMATORY BOWEL DISEASE DIAGNOSIS
por: Singh, N, et al.
Publicado: (2023)

A187 DIETARY FIBERS ELICIT GUT IMMUNE AND EPITHELIAL BARRIER MODIFYING EFFECTS IN INFLAMMATORY BOWEL DISEASES BASED ON FOOD SOURCE AND FIBER CHEMICAL FEATURES
por: Bording-Jorgensen, M, et al.
Publicado: (2023)

A265 TEMPORAL DYNAMICS OF SYMPTOMS AND GUT MICROBIOTA IN EPISODES OF IRRITABLE BOWEL SYNDROME
por: Mohan, V, et al.
Publicado: (2023)

A225 QUANTIFICATION OF BONE DENSITY AND DIETARY RISK FACTORS FOR BONE FRAGILITY IN INFLAMMATORY BOWEL DISEASE
por: Macci, A, et al.
Publicado: (2023)

A199 BIOFILMS IN THE APPENDIX AND OTHER NON-INFLAMED SECTIONS OF THE COLON IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASES
por: Arjomand Fard, N, et al.
Publicado: (2023)

A166 RISK STRATIFICATION OF EARLY RE-HOSPITALIZATION IN PERSONS WITH INFLAMMATORY BOWEL DISEASES USING MULTIVARIABLE MODELS
por: Dziegielewski, C, et al.
Publicado: (2023)

Clinical and genetic analyses in a patient with PAPA syndrome complicated with inflammatory bowel disease
por: Ida, H, et al.
Publicado: (2015)

T.06.4 LONG TERM EFFICACY AND SAFETY OF ABP 501 ADALIMUMAB BIOSIMILAR ON INFLAMMATORY BOWEL DIESASES: THE ADASWITCH STUDY
por: Cingolani, A., et al.
Publicado: (2022)

T.06.3 DOES SARS-COV-2 VACCINATION AFFECT THE COURSE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS ON BIOLOGICAL THERAPY?
por: De Blasio, F., et al.
Publicado: (2022)

A170 ADVERSE EVENTS & SEROLOGICAL RESPONSES FOLLOWING SARS-COV-2 VACCINATION IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
por: Markovinovic, A, et al.
Publicado: (2023)

A191 NONALCOHOLIC FATTY LIVER DISEASE AND LIVER FIBROSIS INCREASE CARDIOVASCULAR RISK IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
por: Kablawi, D, et al.
Publicado: (2023)

A74 URGENCY FOR BOWEL MOVEMENTS IS A HIGHLY DISCRIMINATORY SYMPTOM FOR ACTIVE DISEASE IN PERSONS WITH IBD (THE MANITOBA LIVING WITH IBD STUDY)
por: Kulyk, A, et al.
Publicado: (2023)

87 Intracerebral inflammatory pseudotumor in Behçet’s disease: a pediatric case report
por: Hadef, Djohra, et al.
Publicado: (2022)

A91 INTERACTIONS BETWEEN PREGNANCY, DELIVERY, AND ILEAL POUCH-ANAL ANASTOMOSIS FOR INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE CHART REVIEW
por: House, S C, et al.
Publicado: (2023)

A76 PHYSICIANS PERCEIVED VALUE OF COMPUTED TOMOGRAPHY SCANS FOR INFLAMMATORY BOWEL DISEASE PATIENTS IN THE EMERGENCY DEPARTMENT: A SURVEY OF CANADIAN PHYSICIANS
por: Roda, C, et al.
Publicado: (2023)

A203 EARLY PROACTIVE DRUG MONITORING STRATEGY OF INFLIXIMAB AS MONOTHERAPY FOR INFLAMMATORY BOWEL DISEASE IN PAEDIATRIC PATIENTS IS ASSOCIATED WITH GOOD SUSTAINED CLINICAL REMISSION
por: Girard, C, et al.
Publicado: (2023)

A169 THE DIRECT COSTS OF INFLAMMATORY BOWEL DISEASE IN CANADA: A POPULATION-BASED ANALYSIS OF HISTORICAL AND CURRENT COSTS
por: Coward, S, et al.
Publicado: (2023)

P02.120. Qualitative systemic review on Complementary and Alternative Medicine treatments in Inflammatory Bowel Diseases
por: Langhorst, J, et al.
Publicado: (2012)

A159 RISK OF TOTAL METACHRONOUS ADVANCED NEOPLASIA IN PATIENTS WITH SERRATED LESIONS AND INFLAMMATORY BOWEL DISEASE
por: Medawar, E, et al.
Publicado: (2023)

P008 A systematic review and meta-analysis of inflammatory bowel disease activity and sleep quality
por: Barnes, A, et al.
Publicado: (2021)

A182 PREDICTING HIGH DIRECT HEALTHCARE COSTS IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN THE FIRST YEAR FOLLOWING DIAGNOSIS
por: Kuenzig, E, et al.
Publicado: (2023)

The Effect of Cumulative Dose of Glucocorticoids on Bone in Children with Inflammatory Bowel Disease (3-year Follow- up study)
por: Tomková, S, et al.
Publicado: (2013)

A211 CAN AN EXPERIMENTAL MOUSE MODEL BE USED TO CHARACTERIZE BEHAVIOURAL COMORBIDITIES ASSOCIATED WITH INFLAMMATORY BOWEL DISEASES?
por: Josephson, J, et al.
Publicado: (2023)

A94 EXPLORING THE SOCIOECONOMIC BURDEN OF PEDIATRIC INFLAMMATORY BOWEL DISEASE: A SURVEY OF FAMILIES AND PEDIATRIC PROVIDERS
por: Desai, T, et al.
Publicado: (2023)

A84 FACTORS ASSOCIATED WITH HIGH LEVELS OF TELEPHONE CARE SATISFACTION AMONG INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
por: Foncham, J N, et al.
Publicado: (2023)

A183 VARIATION IN HEALTH SERVICES UTILIZATION AND RISK OF SURGERY ACROSS CHILDREN WITH INFLAMMATORY BOWEL DISEASE: A MULTIPROVINCE COHORT STUDY
por: Kuenzig, E, et al.
Publicado: (2023)

Diet and diet combined with chronic aerobic exercise decreases body fat mass and alters plasma and adipose tissue inflammatory markers in obese women
por: Lakhdar, N, et al.
Publicado: (2015)

A68 HOW REAL ARE YOUR SURVEY RESPONDENTS? IDENTIFYING FRAUDULENT RESPONDENTS IN ONLINE SURVEYS – A CASE EXAMPLE IN INFLAMMATORY BOWEL DISEASE (IBD)
por: MacDonald, K V, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r9cud4gge77ersa5ceqldkp72i